*Pre-Registration Required
Live In-Person Event
Interactive continuing medical education activity for healthcare professionals in Philadelphia, New Jersey, Delaware, and surrounding areas to discuss acute leukemia and myeloid malignancies updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with acute leukemia and myeloid malignancies.
Agenda
5:30 PM – Dinner and Networking
6:30 PM – Welcome, Program Overview, and Updates in Clinical Trials
Catherine Lai, MD, MPH
6:40 PM – Overview of Blood Cancer United Resources
Amanda O’Neill, LMSW
6:45 PM – Case Presentation and Panel Discussion on How I Treat Newly Diagnosed AML with Azacitadine + Venetoclax
Michael A. Brister, MD; Gina Keiffer, MD; Catherine Lai, MD, MPH; Amogh Pathak, MD; Keith Pratz, MD; and Alexander Vartanov, MD
7:30 PM – Case Presentation and Discussion on Reducing Phlebotomy Burden in Patients with PV
Lindsay Wilde, MD and Pavan J. Patel, MD
7:55 PM – Case Presentation and Discussion on Referring Older Adults with MDS/AML for BMT: Who and When
Alexander Vartanov, MD and Aliya Rashid, DO, MPH
8:20 PM – Discussion and wrap-up
All Faculty
8:30 PM – Conclusion
Catherine Lai, MD, MPH
Learning Objectives
At the conclusion of this activity, participants will be better able to:
- Explain the most recent data on novel treatment options in acute leukemias and myeloid malignancies
- Discuss drug interactions with novel therapies and how to manage
- Explain diagnostic and prognostic testing and challenges, relapse prevention and detection of measurable residual disease
- Explain disparities and challenges in the diagnosis and treatment of acute leukemias and myeloid malignancies
- Identify resources for patient education and support
ADVISORY GROUP
Catherine Lai, MD, MPH (Chair)
Hospital of the University of Pennsylvania
Philadelphia, PA
Katie Allen, CRNP
Hospital of the University of Pennsylvania
Philadelphia, PA
Michael A. Brister, MD
Cooper University Health Care
Camden, NJ
Alison Carulli, PharmD, BCOP
Hospital of the University of Pennsylvania
Philadelphia, PA
Margie Kasner, MD, MSCE
Sidney Kimmel Comprehensive Cancer Center
Thomas Jefferson University
Philadelphia, PA
Grace Shyu, PA-C
Hospital of the University of Pennsylvania
Philadelphia, PA
Michael Styler, MD
Fox Chase Cancer Center
Temple University
Philadelphia, PA
FACULTY
Catherine Lai, MD, MPH (Chair)
Hospital of the University of Pennsylvania
Philadelphia, PA
Michael A. Brister, MD
Cooper University Health Care
Camden, NJ
Gina Keiffer, MD
Sidney Kimmel Comprehensive Cancer Center
Thomas Jefferson University Hospital
Philadelphia, PA
Amanda O’Neill, LMSW
Blood Cancer United
Washington, DC
Amogh Pathak, MD
MD Anderson Cancer Center at Cooper
Camden, NJ
Pavan J. Patel, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Keith Pratz, MD
Hospital of the University of Pennsylvania
Philadelphia, PA
Aliya Rashid, DO, MPH
Fox Chase Cancer Center
Temple University
Philadelphia, PA
Alexander Vartanov, MD
Fox Chase Cancer Center
Temple University
Philadelphia, PA
Lindsay R. Wilde, MD
Sidney Kimmel Comprehensive Cancer Center
Thomas Jefferson University Hospital
Philadelphia, PA
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Blood Cancer United and Medical Learning Institute Inc. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of Blood Cancer United under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-25-036-L01-P
For Pharmacists, Medical Learning Institute Inc will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form, and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at [email protected].
Providers
This activity is provided by Blood Cancer United and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporters
Blood Cancer United thanks Autolus Therapeutics, Geron Corporation, and Novartis Pharmaceuticals Corporation for their financial support.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at [email protected].